Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-γ, TGF-β, and cell density

被引:184
作者
Romieu-Mourez, Raphaelle
Francois, Moira
Boivin, Marie-Noelle
Stagg, John
Galipeau, Jacques
机构
[1] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Med Oncol, Montreal, PQ, Canada
[2] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada
关键词
D O I
10.4049/jimmunol.179.3.1549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Mesenchymal stromal cells (MSC) possess immunosuppressive properties, yet when treated with IFN-gamma they acquire APC functions. To gain insight into MSC immune plasticity, we explored signaling pathways induced by IFN-gamma required for MHC class II (MHC II)-dependent Ag presentation. IFN-gamma-induced MHC II expression in mouse NISC was enhanced by high cell density or serum deprivation and suppressed by TGF-beta. This process was regulated by the activity of the type IV CIITA promoter independently of STAT1 activation and the induction of the IFN regulatory factor 1-dependent B7H1/PD-L1 encoding gene. The absence of direct correlation with the cell cycle suggested that cellular connectivity modulates IFN-gamma responsiveness for MHC II expression in mouse MSC. TGF-beta signaling in mouse NISC involved ALK5 and ALK1 TGF-beta RI, leading to the phosphorylation of Smad2/Smad3 and Smad1/Smad5/Smad8. An opposite effect was observed in human MSC where IFN-gamma-induced MHC II expression occurred at the highest levels in low-density cultures; however, TGF-beta reduced IFN-gamma-induced MHC II expression and its signaling was similar as in mouse MSC. This suggests that the IFN--y-induced APC features of NISC can be modulated by TGF-beta, serum factors, and cell density in vitro, although not in the same way in mouse and human NISC, via their convergent effects on CHTA expression.
引用
收藏
页码:1549 / 1558
页数:10
相关论文
共 47 条
[1]
IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS [J].
ATTISANO, L ;
CARCAMO, J ;
VENTURA, F ;
WEIS, FMB ;
MASSAGUE, J ;
WRANA, JL .
CELL, 1993, 75 (04) :671-680
[2]
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[3]
Cancelas JA, 2000, BLOOD, V96, P498
[4]
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ [J].
Chan, Jennifer L. ;
Tang, Katherine C. ;
Patel, Anoop P. ;
Bonilla, Larissa M. ;
Pierobon, Nicola ;
Ponzio, Nicholas M. ;
Rameshwar, Pranela .
BLOOD, 2006, 107 (12) :4817-4824
[5]
Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors [J].
Chen, YG ;
Massagué, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) :3672-3677
[6]
Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane [J].
Chow, A ;
Toomre, D ;
Garrett, W ;
Mellman, I .
NATURE, 2002, 418 (6901) :988-994
[7]
Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells [J].
Colter, DC ;
Sekiya, I ;
Prockop, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7841-7845
[8]
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals [J].
Djouad, F ;
Plence, P ;
Bony, C ;
Tropel, P ;
Apparailly, F ;
Sany, J ;
Noël, D ;
Jorgensen, C .
BLOOD, 2003, 102 (10) :3837-3844
[9]
The Smad3 protein is involved in TGF-β inhibition of class II transactivator and class II MHC expression [J].
Dong, YS ;
Tang, LP ;
Letterio, JJ ;
Benveniste, EN .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :311-319
[10]
CONNEXIN-43 TYPE GAP-JUNCTIONS MEDIATE COMMUNICATION BETWEEN BONE-MARROW STROMAL CELLS [J].
DORSHKIND, K ;
GREEN, L ;
GODWIN, A ;
FLETCHER, WH .
BLOOD, 1993, 82 (01) :38-45